Globus Medical Inc  

(Public, NYSE:GMED)   Watch this stock  
Find more results for GMED
27.45
-0.11 (-0.40%)
Aug 4 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 27.32 - 27.71
52 week 17.45 - 28.99
Open 27.46
Vol / Avg. 462,011.00/427,333.00
Mkt cap 2.62B
P/E 26.45
Div/yield     -
EPS 1.04
Shares 71.19M
Beta     -
Inst. own 89%

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 18.01% 19.50%
Operating margin 27.72% 29.17%
EBITD margin - 34.95%
Return on average assets 12.79% 14.57%
Return on average equity 15.35% 17.49%
Employees 900 -
CDP Score - -

Address

2560 General Armistead Ave
AUDUBON, PA 19403-5214
United States - Map
+1-610-9301800 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders and spine disorders. Its products consist of two categories: Innovative Fusion and Disruptive Technologies. Innovative Fusion products comprise fusion products to treat various spinal disorders for the entire spine and can be used in various surgical approaches. Disruptive Technologies represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. The Company’s portfolio of Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques, as well as treatment alternatives, including motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and biomaterials technologies, as well as interventional pain management solutions.

Officers and directors

David C. Paul Chairman of the Board, Chief Executive Officer
Age: 48
David M. Demski President, Chief Operating Officer, Director
Age: 57
Daniel T Scavilla Chief Financial Officer, Senior Vice President
Age: 50
A. Brett Murphy Executive Vice President, US Sales
Age: 50
Anthony Williams Senior Vice President, General Counsel
Age: 44
David D. Davidar Senior Vice President - Operations , Director
Age: 48
Daniel T. Lemaitre Independent Director
Age: 61
Robert W. Liptak CPA Independent Director
Age: 51
Ann D. Rhoads Independent Director
Age: 53
Kurt C. Wheeler Independent Director
Age: 62